ChemFeeds Site Navigation:
Journal Selection:
Search:

99) TP53 Mutations in Advanced NSCLC (Clinical Cancer Research) Tuesday September 2nd 2014


100) Role of miR-409 in Prostate Cancer Bone Metastasis (Clinical Cancer Research) Tuesday September 2nd 2014


101) Androgen and Estrogen Signaling and Stem Cell Markers in Prostate Cancer (Clinical Cancer Research) Tuesday September 2nd 2014


102) Deep Sequencing of Plasma DNA for Tumor Mutation Diagnosis (Clinical Cancer Research) Tuesday September 2nd 2014


103) Gastric Cancer Methylome and Metastasis Biomarkers (Clinical Cancer Research) Tuesday September 2nd 2014


104) LSD1 Inhibitor Blocks Oncogenic EWS/ETS Function (Clinical Cancer Research) Tuesday September 2nd 2014


105) SAR650984: A Novel Antibody for CD38+ Malignancies (Clinical Cancer Research) Tuesday September 2nd 2014


106) Multiple RTKs Confer Lapatinib Unresponsiveness in HER2+ GC (Clinical Cancer Research) Tuesday September 2nd 2014


107) Ang1 and Tie2 Are Predictive Biomarkers for Bevacizumab (Clinical Cancer Research) Tuesday September 2nd 2014


108) MRD Detection by Sequencing in B-ALL (Clinical Cancer Research) Tuesday September 2nd 2014


109) Glutamate Predicts Survival in Medulloblastoma (Clinical Cancer Research) Tuesday September 2nd 2014


110) Determinants of In Vivo ABT-263 Response (Clinical Cancer Research) Tuesday September 2nd 2014


111) Fc{gamma}RIIa and Fc{gamma}RIIIa Polymorphisms and Cetuximab (Clinical Cancer Research) Tuesday September 2nd 2014


112) The KRAS-Variant Predicts Cetuximab Response in Colon Cancer (Clinical Cancer Research) Tuesday September 2nd 2014


113) Biomarkers for Onartuzumab + Erlotinib Therapy in NSCLC (Clinical Cancer Research) Tuesday September 2nd 2014


114) EGFR Expression and Cetuximab Activity in Xenograft Models of NSCLC (Clinical Cancer Research) Tuesday September 2nd 2014


115) Phase I of Inecalcitol with Docetaxel in mCRPC Patients (Clinical Cancer Research) Tuesday September 2nd 2014


116) p53MVA Therapy for Gastrointestinal Cancer (Clinical Cancer Research) Tuesday September 2nd 2014


117) Dabrafenib Dose Selection, Pharmacokinetics, and Pharmacodynamics (Clinical Cancer Research) Tuesday September 2nd 2014


118) ETS Gene Fusions in Cancer (Clinical Cancer Research) Tuesday September 2nd 2014


119) FDA Approval Summary for T-DM1 for HER2+ MBC (Clinical Cancer Research) Tuesday September 2nd 2014


120) Molecular Markers for Personalized Medicine (Clinical Cancer Research) Tuesday September 2nd 2014


121) Rapid Co-development of Drugs and Biomarkers: Is a Single Companion Diagnostic Optimal? (Clinical Cancer Research) Tuesday September 2nd 2014


122) TP53 Mutations and Lung Cancer (Clinical Cancer Research) Tuesday September 2nd 2014


123) Correction: Bim Polymorphisms: Influence on Function and Response to Treatment in Children with Acute Lymphoblastic Leukemia (Clinical Cancer Research) Thursday August 14th 2014


124) Correction: A Phase I Trial of LY2510924, a CXCR4 Peptide Antagonist, in Patients with Advanced Cancer (Clinical Cancer Research) Thursday August 14th 2014


125) Correction: Interleukin-7 Mediates Selective Expansion of Tumor-Redirected Cytotoxic T Lymphocytes (CTLs) without Enhancement of Regulatory T-Cell Inhibition (Clinical Cancer Research) Thursday August 14th 2014


126) PBX1 Promotes Differentiation in Neuroblastoma (Clinical Cancer Research) Thursday August 14th 2014


127) IL4+ and IL17+ Melan-A-Reactive T Cells in Melanoma (Clinical Cancer Research) Thursday August 14th 2014


128) Combined GNAS and KRAS Testing (Clinical Cancer Research) Thursday August 14th 2014


129) Regulation of Pancreatic Cancer Metabolism by KLF4 (Clinical Cancer Research) Thursday August 14th 2014


130) GCC Lymph Node Ratio and Colon Cancer Recurrence (Clinical Cancer Research) Thursday August 14th 2014


131) Aberrant Methylation of Enhancers in Renal Cell Cancer (Clinical Cancer Research) Thursday August 14th 2014


132) Skin Barrier Dysfunction in CTCL (Clinical Cancer Research) Thursday August 14th 2014


133) Activated Stellate Cells Promote Perineural Invasion (Clinical Cancer Research) Thursday August 14th 2014


134) Resistance to Endocrine Treatment in Luminal Breast Cancer Xenografts (Clinical Cancer Research) Thursday August 14th 2014


135) Selective Targeting of Tumor Cells by DPP-23 (Clinical Cancer Research) Thursday August 14th 2014


136) O3/O2-Pneumoperitoneum-Induced Tumoricidal Immunity (Clinical Cancer Research) Thursday August 14th 2014


137) Functional Kinomics Identifies Therapeutic Targets in HNSCC (Clinical Cancer Research) Thursday August 14th 2014


138) Solid Tumor Induction of CAR T-cell Hypofunction (Clinical Cancer Research) Thursday August 14th 2014


139) MEK Inhibitor RO4987655 in Patients with Solid Tumors (Clinical Cancer Research) Thursday August 14th 2014


140) Rilotumumab, Ganitumab, and Panitumumab in Treatment of mCRC (Clinical Cancer Research) Thursday August 14th 2014


141) Multiple WT1 Peptide-Pulsed Dendritic Cell Vaccines (Clinical Cancer Research) Thursday August 14th 2014


142) Single-Agent Orteronel in Castration-Resistant nmCRPC (Clinical Cancer Research) Thursday August 14th 2014


143) Recommendations for Design of Phase I Combination Trials (Clinical Cancer Research) Thursday August 14th 2014


144) Drug Development for Metastatic Progression in Osteosarcoma (Clinical Cancer Research) Thursday August 14th 2014


145) MEK Inhibitors in KRAS-Mutant Cancers (Clinical Cancer Research) Thursday August 14th 2014


146) NRAS Mutations in Melanoma and AML (Clinical Cancer Research) Thursday August 14th 2014


147) Historical Controls for Advanced Pancreatic Cancer Trials (Clinical Cancer Research) Thursday August 14th 2014


148) CHK It Out! (Clinical Cancer Research) Thursday August 14th 2014


149) Correction: hERG1 Channels Regulate VEGF-A Secretion in Human Gastric Cancer: Clinicopathological Correlations and Therapeutical Implications (Clinical Cancer Research) Friday August 1st 2014


150) Hepatic Uptake Transporters and Docetaxel Disposition in Mice--Letter (Clinical Cancer Research) Friday August 1st 2014


151) ALDH1A3 in Non-Small Cell Lung Cancer Stem Cells (Clinical Cancer Research) Friday August 1st 2014


152) microRNA Expression in CLL (Clinical Cancer Research) Friday August 1st 2014


153) Next-Generation Sequencing of Translocation RCC (Clinical Cancer Research) Friday August 1st 2014


154) An Unconventional Oncogenic Signal of EGF (Clinical Cancer Research) Friday August 1st 2014


155) FGFR1/3 Tyrosine Kinase Fusions in Non-Small Cell Lung Cancer (Clinical Cancer Research) Friday August 1st 2014


156) Rescue of NK Cells by Blocking the Induction of MDSCs (Clinical Cancer Research) Friday August 1st 2014


157) CtBP1 and High-Fat Diet Regulate Prostate Cancer Growth (Clinical Cancer Research) Friday August 1st 2014


158) Galeterone Actions as AR Antagonist (Clinical Cancer Research) Friday August 1st 2014


159) Phosphoproteomics of EGFR-TKI Resistance (Clinical Cancer Research) Friday August 1st 2014


160) Synergistic PI3K2 and EGFR Inhibitors for PDACA (Clinical Cancer Research) Friday August 1st 2014


161) Fc-Enhanced TCR-like Antibody against WT1 Peptide/HLA-A2 (Clinical Cancer Research) Friday August 1st 2014


162) Cisplatin Nephrotoxicity Is Dependent on OCT2 and p53 (Clinical Cancer Research) Friday August 1st 2014


163) NADPH Oxidase Inhibitors and BCR-ABL Inhibitors Synergize (Clinical Cancer Research) Friday August 1st 2014


164) BCMab1 Has Antitumor Activity to Bladder Cancer (Clinical Cancer Research) Friday August 1st 2014


165) CS1-Specific CAR T Cells for Myeloma Immunotherapy (Clinical Cancer Research) Friday August 1st 2014


166) Hedgehog Signaling in CD44(+) Gastric Cancer Cells (Clinical Cancer Research) Friday August 1st 2014


167) Transcriptional Response to Fulvestrant and Anastrozole (Clinical Cancer Research) Friday August 1st 2014


168) Biomarkers of Bone Remodeling to Tailor Bisphosphonates (Clinical Cancer Research) Friday August 1st 2014


169) Biomarkers of HSP90 Inhibition in Metastatic Breast Cancer (Clinical Cancer Research) Friday August 1st 2014


170) Physiologically Based Pharmacokinetic Model of Veliparib (Clinical Cancer Research) Friday August 1st 2014


171) A RAS Renaissance (Clinical Cancer Research) Friday August 1st 2014


172) Smac Mimetics and Death Receptors (Clinical Cancer Research) Friday August 1st 2014


173) DUBs as Novel Cancer Targets (Clinical Cancer Research) Friday August 1st 2014


174) FDA Approval of Obinutuzumab for CLL (Clinical Cancer Research) Friday August 1st 2014


175) CAR T Cells Targeting CS1 for Myeloma (Clinical Cancer Research) Friday August 1st 2014


176) Correction: Mesothelin Overexpression Is a Marker of Tumor Aggressiveness and Is Associated with Reduced Recurrence-Free and Overall Survival in Early-Stage Lung Adenocarcinoma (Clinical Cancer Research) Tuesday July 15th 2014


177) Impact of FANCD2 in Alveolar Rhabdomyosarcoma (Clinical Cancer Research) Tuesday July 15th 2014


178) Biospecimen Variables Affect Biomarkers (Clinical Cancer Research) Tuesday July 15th 2014


179) Clustering of Neural Autoantibodies (Clinical Cancer Research) Tuesday July 15th 2014


180) VEGF/VEGFR-2 Induces EZH2 Expression in Lung Adenocarcinoma (Clinical Cancer Research) Tuesday July 15th 2014


181) Genomic Analysis of Young Tongue Cancer (Clinical Cancer Research) Tuesday July 15th 2014


182) Circulating Tumor Cells in Testicular Germ Cell Tumors (Clinical Cancer Research) Tuesday July 15th 2014


183) Prognostic B-cell Signatures in Breast and Ovarian Cancer (Clinical Cancer Research) Tuesday July 15th 2014


184) Three-Protein Panel Predicts Colorectal Cancer Prognosis (Clinical Cancer Research) Tuesday July 15th 2014


185) Expression of Cancer-Testis Antigens in CTCL (Clinical Cancer Research) Tuesday July 15th 2014


186) Oncolytic HSV-1 Virotherapy Synergizes with Bortezomib (Clinical Cancer Research) Tuesday July 15th 2014


187) MEK Inhibitor Overcomes Resistance to Cetuximab in Colorectal Cancer (Clinical Cancer Research) Tuesday July 15th 2014


188) Semi-Mechanistic PK/PD Modeling of LY2835219 in Mouse (Clinical Cancer Research) Tuesday July 15th 2014


189) CSPG4 Immunotherapy for Canine Malignant Melanoma (Clinical Cancer Research) Tuesday July 15th 2014


190) Optimization of MDM2 Antagonist RG7388 for Clinical Testing (Clinical Cancer Research) Tuesday July 15th 2014


191) Chemopotentiating Effects of PARP Inhibition in GBM (Clinical Cancer Research) Tuesday July 15th 2014


192) GRPR Photoacoustic Imaging Agent for Imaging Prostate Cancer (Clinical Cancer Research) Tuesday July 15th 2014


193) Mutational Analysis of Germ Cell Tumors (Clinical Cancer Research) Tuesday July 15th 2014


194) Diffusion-Weighted MRI in Prostate Cancer: Prediction of Aggressiveness (Clinical Cancer Research) Tuesday July 15th 2014


195) PAP DNA Vaccine Immune Monitoring in Patients with CRPC (Clinical Cancer Research) Tuesday July 15th 2014


196) Safety and Pharmacology of VTX-2337 (Clinical Cancer Research) Tuesday July 15th 2014


View: prev | next

#RealTimeChem:

Announcements:

Chem News Feed:

Before last week my understanding of space suits was based on...

BOO

Product review: Perkin Elmer's Elements electronic notebook

In defense of the rainbow flame demonstration

Daily Pump Trap: 10/30/14 edition

Shedding Light On Cell Mechanics

Science And Dramatic Art: Any Intersections?

Formal Total Synthesis of (–)-Taxol

Compound Reverses The Anticlotting Effects Of Heparin

Oil Rose And Then Fell After Deepwater Horizon Disaster


Lab Death Legal Defense Cost University Of California Nearly $4.5 Million

Reactive Lewis Pairs Hydrogenate Carbonyls

Sasol Moves Ahead On Louisiana Ethylene

Big Chemical Firms See Strong Third Quarter


Nivolumab Racks Up Another Success


Mitch Andre Garcia's Chem Feeds 2008-present

Some images have been reproduced by permission of The Royal Society of Chemistry. (RSC' RSS Policy)
Other images have been reproduced with permission of the American Chemical Society. (ACS' RSS Policy)
Few images have been reproduced with pending permission of Wiley-VCH. ()